If your hair is falling out faster than it should, the answer is rarely a better shampoo. It is almost always a message from your hormones.
Take the Free Hormone QuizThis guide breaks down the specific hormones involved in hair loss, how to tell which one is driving yours, what the evidence says about treatment, and what targeted, root-cause steps actually produce results for South African women.
Hormonal hair loss in women is most commonly driven by five overlapping causes: excess androgens (as in PCOS), falling oestrogen and progesterone during perimenopause, thyroid dysfunction, elevated cortisol from chronic stress, and post-pill shedding following contraceptive use. Each cause has a distinct pattern, a distinct mechanism, and a distinct treatment approach. Identifying which hormonal driver applies to you is the starting point, because treating androgenic hair loss with the same approach as thyroid-driven shedding produces poor results. Comprehensive hormone testing is far more useful than trying biotin supplements and hoping for the best.
Every hair follicle on your scalp cycles through three phases: anagen (active growth, lasting two to seven years), catagen (transition, lasting two to three weeks), and telogen (rest and shedding, lasting two to four months). At any given time, roughly 85 to 90 percent of your follicles should be in the growth phase, with the remainder resting. Hormones are the primary regulators of this cycle. They determine how long each follicle stays in the growth phase, how thick each strand grows, and how quickly follicles re-enter growth after shedding.
When hormonal balance is disrupted, one of two things typically happens. The first is a shortening of the anagen growth phase, so hairs shed before they reach their full potential length and density. The second is follicle miniaturisation, where androgens cause the follicle itself to shrink over successive cycles, producing progressively finer and shorter strands until the follicle eventually stops producing visible hair altogether. Understanding which mechanism is at play in your case directly determines which treatment approach is appropriate.
“One of the most common presentations I see is a woman who comes off the contraceptive pill and starts losing hair three to four months later. She goes to her GP, gets a basic thyroid test and ferritin, both come back normal, and is told her hair loss is unrelated to stopping the pill. In most cases it is directly related. Post-pill shedding is real, it is well-described in the literature, and it is almost always compounded by the nutrient depletion that long-term pill use creates. Zinc, B6, B12, folate, magnesium: all depleted by synthetic hormones, all essential for hair growth. Addressing these systematically produces results in ways that no topical treatment ever could.”Dr Olwethu Sotondoshe | Natural Hormone Health Practitioner & Homeopath | Ask Dr Olz
The pattern and timing of hair loss provides important diagnostic information before any testing is done. Use the table below as a starting point.
| Hair Loss Pattern | Most Likely Driver | Key Associated Symptoms |
|---|---|---|
| Thinning at crown and temples, widening part | Androgenic (DHT-driven), PCOS | Acne, irregular periods, weight gain, excess facial hair |
| Diffuse thinning across entire scalp | Thyroid dysfunction or telogen effluvium | Fatigue, cold intolerance, dry skin, constipation |
| Sudden heavy shedding, began 2 to 4 months after a trigger | Telogen effluvium from stress or post-pill | Recent stress, illness, surgery, or stopping the pill |
| General thinning with finer texture, beginning in 40s | Perimenopausal oestrogen and progesterone decline | Hot flushes, cycle changes, sleep disruption, mood shifts |
| Outer third of eyebrows also thinning | Thyroid dysfunction (classic hypothyroid sign) | Low energy, weight gain, brain fog, low mood |
Note: These patterns overlap, and more than one driver can be present simultaneously. A woman in perimenopause with underlying PCOS and chronic stress may be experiencing all three mechanisms at once. Proper testing is the only way to quantify each contributor accurately.
Hormonal drivers do not act in isolation. Several nutritional deficiencies directly impair hair follicle function and amplify the impact of hormonal imbalance on hair growth. These are the most clinically relevant in South African women.
Dr Olz has reviewed the evidence and compiled a guide to the best hair loss supplements available in South Africa, including what to look for, what to avoid, and which nutrients to prioritise based on your specific pattern.
Read: 7 Best Hair Loss Supplements in South AfricaTreating hormonal hair loss effectively means treating the hormone driving it, not the hair. Topical treatments, thickening shampoos, and even prescription minoxidil produce limited and temporary results when the underlying hormonal signal is still actively shortening growth phases or miniaturising follicles. Here is how a root-cause approach is structured.
A comprehensive hair loss panel should include free and total testosterone, DHEA-S, sex hormone binding globulin (SHBG), oestradiol, progesterone, a full thyroid panel including free T3 and reverse T3, fasting insulin and glucose, ferritin, vitamin D, zinc, and B12. This level of testing consistently reveals patterns that a basic thyroid and ferritin check misses. Our complete guide to hormone imbalance in South African women covers testing options in detail, including the DUTCH test for advanced assessment.
For androgenic hair loss driven by elevated DHT, the clinical approach focuses on reducing 5-alpha reductase activity, lowering androgens by addressing insulin resistance, and supporting oestrogen-progesterone balance. Saw palmetto has the strongest evidence base among natural 5-alpha reductase inhibitors. For perimenopausal hair loss, supporting oestrogen and progesterone levels through the transition, via nutritional and where indicated bioidentical means, directly addresses the mechanism. For thyroid-driven loss, optimising T3 conversion is the target rather than simply adjusting TSH.
Nutrient correction based on actual test results, using clinically relevant doses in bioavailable forms, produces consistently better outcomes than generic hair supplement blends. Ferritin should be restored to above 70 mcg/L, not merely above the bottom of the reference range. Zinc picolinate or zinc bisglycinate is significantly better absorbed than zinc oxide. Vitamin D3 with K2 is the appropriate combination for effective tissue delivery. For a detailed, evidence-reviewed breakdown of which hair supplements are worth considering for South African women, see the 7 best hair loss supplements in South Africa on the Ask Dr Olz website.
Chronic elevated cortisol is an underappreciated but extremely common driver of hair loss that is rarely addressed in conventional treatment. Adaptogenic herbs including ashwagandha and rhodiola, targeted magnesium glycinate, sleep optimisation, and deliberate stress load management reduce the cortisol-driven follicle shutdown that compounds every other type of hair loss. No targeted hair treatment works optimally against a background of chronic physiological stress.
While root-cause hormonal work is the primary intervention, scalp health genuinely matters. Adequate blood flow to follicles, reduced scalp inflammation (often worsened by insulin resistance and gut dysbiosis), and a clean-label scalp care routine free from hormone-disrupting ingredients support the environment in which follicles have to function. This is the appropriate role for topical care: complementary to hormonal treatment, not a replacement for it.
“Hair regrowth after hormonal correction is slow because the follicle cycle is slow. Women typically begin to notice reduced shedding within six to eight weeks of addressing the underlying driver, but visible regrowth takes three to six months, and full density recovery can take twelve months or more. This timeline is why it is so important to start with the right approach rather than cycling through products that do not address the root cause. The biology is straightforward: restore the hormonal signal, provide the nutritional raw materials, reduce the inflammatory and cortisol load, and the follicles respond.”Dr Olwethu Sotondoshe | Natural Hormone Health Practitioner & Homeopath | Ask Dr Olz
Understanding what to avoid is as important as knowing what to do, because the hair loss supplement and treatment market is particularly saturated with products that are sold with compelling marketing but thin clinical evidence.
Biotin supplementation is appropriate when a genuine biotin deficiency has been identified. In the absence of deficiency, high-dose biotin does not improve hair growth and can interfere with thyroid blood test results, producing falsely elevated or suppressed readings that then lead to incorrect clinical decisions. Biotin is not a universal hair growth driver. It is one nutrient among many, and only relevant when low.
Minoxidil, rosemary oil, and other topical treatments can support hair density by extending the anagen phase locally. They do not address the hormonal signal that is shortening growth phases from within. Used alone without hormonal correction, results are partial and typically regress once the product is stopped.
Starting with a supplement stack or a prescription treatment before identifying which hormonal driver is present is inefficient at best and counterproductive at worst. Saw palmetto is appropriate for androgenic hair loss but irrelevant for thyroid-driven diffuse shedding. Iron supplementation is critical when ferritin is low but unnecessary when ferritin is adequate. Treatment without testing is guesswork.
Take the free Hormone Assessment Quiz to identify which hormonal pattern is most likely driving your hair loss, built specifically for South African women.
Take the Free Quiz NowSeveral hormones are involved. Dihydrotestosterone (DHT), a potent androgen converted from testosterone, is the primary driver of patterned follicle miniaturisation. Falling oestrogen and progesterone during perimenopause shorten the growth phase and remove the natural inhibition of DHT activity. Low thyroid hormone slows follicle cell activity. Elevated cortisol from chronic stress prematurely pushes follicles into the resting phase. Most women with significant hair loss have more than one of these operating simultaneously.
In most cases, yes, provided the hormonal driver is identified and addressed before permanent follicle damage has occurred. Telogen effluvium from stress or post-pill shedding typically resolves fully with the right nutritional and hormonal support. Androgenic hair loss is more challenging but responds well to DHT inhibition, androgen reduction, and nutritional correction. Thyroid-driven diffuse shedding generally improves meaningfully once thyroid function is optimised. Timeline to visible regrowth is three to six months from starting the correct treatment.
It can, in two distinct ways. Some combined oral contraceptives contain progestins with androgenic activity that can drive DHT-related hair loss during use, particularly in women who are genetically predisposed. The more common pattern is post-pill telogen effluvium, where significant diffuse shedding begins three to six months after stopping the pill, as follicles that were held in the growth phase by synthetic oestrogen synchronise into the resting phase together.
A comprehensive hair loss panel should include free and total testosterone, DHEA-S, SHBG, oestradiol, progesterone, a full thyroid panel with free T3 and reverse T3, fasting insulin and glucose, ferritin (with an optimal target above 70 mcg/L, not just in range), vitamin D, zinc, and B12. This goes considerably further than the standard ferritin and TSH that most GPs order, and the additional markers frequently reveal the specific driver that standard testing misses.
Reduced shedding is typically noticeable within six to eight weeks of addressing the hormonal driver and correcting nutritional deficiencies. Visible new growth generally appears at three to six months. Full density recovery can take nine to twelve months or longer, depending on the severity of loss and how long the underlying driver was active before treatment began. Consistency with treatment and realistic expectations about timeline are both essential.